To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Patients With Selected Solid Tumors
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study includes 2 parts. Part 1 is a safety run-in stage and part 2 is to assess the
efficacy and safety of tislelizumab in combination with lenvatinib